Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie K Andersen

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Nature Medicine|August 10, 2004
Oxidative stress in neurodegeneration: cause or consequence?Julie K Andersen
Science Translational Medicine|April 7, 2010
Arvid Carlsson: an early pioneer in translational medicineJulie K Andersen
Current Opinion in Neurobiology|March 10, 2026
Implications of cellular senescence in Parkinson's disease: Recent developments and future directionsJulie K Andersen
Neurotoxicity Research|January 13, 2004
Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's diseaseJulie K Andersen
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Iron dysregulation and Parkinson's diseaseJulie K Andersen
IUBMB Life|July 26, 2003
The role of c-Jun N-terminal kinase (JNK) in Parkinson's diseaseJun Peng, Julie K Andersen
Aging Cell|November 27, 2010
Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseJun Peng, Julie K Andersen
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 17, 2018
Screening Method for Identifying Toxicants Capable of Inducing Astrocyte SenescenceGeorgia Woods, Julie K Andersen
Aging Cell|July 29, 2003
Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?Deepinder Kaur, Julie K Andersen
Cell Cycle (Georgetown, Tex.)|December 14, 2011
Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson diseaseShankar J Chinta, Julie K Andersen
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Nature Medicine|August 10, 2004
Oxidative stress in neurodegeneration: cause or consequence?Julie K Andersen
Science Translational Medicine|April 7, 2010
Arvid Carlsson: an early pioneer in translational medicineJulie K Andersen
Current Opinion in Neurobiology|March 10, 2026
Implications of cellular senescence in Parkinson's disease: Recent developments and future directionsJulie K Andersen
Neurotoxicity Research|January 13, 2004
Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's diseaseJulie K Andersen
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Iron dysregulation and Parkinson's diseaseJulie K Andersen
IUBMB Life|July 26, 2003
The role of c-Jun N-terminal kinase (JNK) in Parkinson's diseaseJun Peng, Julie K Andersen
Aging Cell|November 27, 2010
Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseJun Peng, Julie K Andersen
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 17, 2018
Screening Method for Identifying Toxicants Capable of Inducing Astrocyte SenescenceGeorgia Woods, Julie K Andersen
Aging Cell|July 29, 2003
Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?Deepinder Kaur, Julie K Andersen
Cell Cycle (Georgetown, Tex.)|December 14, 2011
Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson diseaseShankar J Chinta, Julie K Andersen
Pageof 13